Plexus (PLXS) Projected to Post Quarterly Earnings on Wednesday

Plexus (NASDAQ:PLXS) is expected to post its quarterly earnings results after the market closes on Wednesday, April 23rd. Analysts expect Plexus to post earnings of $1.54 per share and revenue of $980.07 million for the quarter. Plexus has set its Q2 2025 guidance at 1.460-1.610 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Stock Performance

Shares of NASDAQ PLXS opened at $122.18 on Wednesday. The firm has a 50 day moving average of $128.31 and a 200 day moving average of $144.82. The firm has a market capitalization of $3.30 billion, a price-to-earnings ratio of 28.35 and a beta of 0.83. Plexus has a 12-month low of $92.72 and a 12-month high of $172.89. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07.

Insider Buying and Selling at Plexus

In other Plexus news, insider Frank Zycinski sold 1,200 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $140.84, for a total value of $169,008.00. Following the completion of the sale, the insider now directly owns 723 shares of the company’s stock, valued at $101,827.32. This trade represents a 62.40 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Patrick John Jermain sold 3,361 shares of the firm’s stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $144.57, for a total transaction of $485,899.77. Following the sale, the chief financial officer now owns 20,745 shares of the company’s stock, valued at $2,999,104.65. This represents a 13.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 17,958 shares of company stock valued at $2,551,930 over the last ninety days. Corporate insiders own 1.76% of the company’s stock.

Analyst Upgrades and Downgrades

PLXS has been the subject of several research analyst reports. Needham & Company LLC raised their target price on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Stifel Nicolaus started coverage on shares of Plexus in a research note on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price target on the stock. Finally, Benchmark reissued a “buy” rating and set a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $163.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.